SCHEDULE OF WARRANT ACTIVITY (Details) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Equity [Abstract] | ||
| Warrants outstanding, Beginning | 1,154 | 3,154 |
| Warrants Weighted Average Exercise Price, Beginning | $ 8.80 | $ 8.80 |
| Warrants Aggregate Intrinsic Value, Ending | ||
| Warrant Issued | 212,548 | |
| Warrants Weighted Average Exercise Price, Issued | $ 11.55 | |
| Warrants Aggregate Intrinsic Value, Issued | ||
| Warrants Exercised | 46,786 | |
| Warrants Weighted Average Exercise Price, Exercised | $ 10.00 | |
| Warrants Expired | 129,832 | 2,000 |
| Warrants Weighted Average Exercise Price, Expired | $ 9.82 | |
| Warrants outstanding, Ending | 37,083 | 1,154 |
| Warrants Weighted Average Exercise Price, Ending | $ 19.52 | $ 8.80 |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non options forfeitures and expirations in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangements by share based payment award non options exercises in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangements by share based payment award non options issued in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Sharebased Compensation Arrangement by Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Issued No definition available.
|
| X | ||||||||||
- Definition Warrants issued No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. No definition available.
|